These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 32709574)

  • 1. [Analysis of fatality rates case of SARS-CoV-2 infection in the Autonomous Communities of Spain].
    Martín-Sánchez V; Barquilla-García A; Vitelli-Storelli F; Segura-Fragoso A; Ruiz-García A; Serrano-Cumplido A; Olmo-Quintana V; Calderón-Montero A
    Semergen; 2020 Aug; 46 Suppl 1():12-19. PubMed ID: 32709574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Case-fatality rates of SARS-CoV-2 infection according to Autonomous Communities during the second epidemic wave in Spain].
    Ruiz-García A; Vitelli-Storelli F; Serrano-Cumplido A; Segura-Fragoso A; Calderón-Montero A; Mico-Pérez RM; Barquilla-García A; Morán-Bayón Á; Linares M; Olmo-Quintana V; Martín-Sánchez V;
    Semergen; 2022; 48(4):252-262. PubMed ID: 35437189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of case fatality rate of SARS-CoV-2 infection in the Spanish Autonomous Communities between March and May 2020.
    V MS; A CM; A BG; F VS; A SF; V OQ; A SC;
    PLoS One; 2021; 16(12):e0260769. PubMed ID: 34860848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case-fatality rate of SARS-CoV-2 infection during the third and fifth epidemic waves in Spain: Impact of vaccination.
    Martín-Sánchez V; Ruiz-Garcia A; Vitelli-Storelli F; Serrano-Cumplido A; Barquilla-Garcia A; Micó-Pérez RM; Olmo-Quintana V; Calderón-Montero A; Segura-Fragoso A
    Semergen; 2023 Oct; 49(7):102026. PubMed ID: 37356278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of lockdown on Covid-19 case fatality rate and viral mutations spread in 7 countries in Europe and North America.
    Pachetti M; Marini B; Giudici F; Benedetti F; Angeletti S; Ciccozzi M; Masciovecchio C; Ippodrino R; Zella D
    J Transl Med; 2020 Sep; 18(1):338. PubMed ID: 32878627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infection fatality risk for SARS-CoV-2 in community dwelling population of Spain: nationwide seroepidemiological study.
    Pastor-Barriuso R; Pérez-Gómez B; Hernán MA; Pérez-Olmeda M; Yotti R; Oteo-Iglesias J; Sanmartín JL; León-Gómez I; Fernández-García A; Fernández-Navarro P; Cruz I; Martín M; Delgado-Sanz C; Fernández de Larrea N; León Paniagua J; Muñoz-Montalvo JF; Blanco F; Larrauri A; Pollán M;
    BMJ; 2020 Nov; 371():m4509. PubMed ID: 33246972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study.
    Pollán M; Pérez-Gómez B; Pastor-Barriuso R; Oteo J; Hernán MA; Pérez-Olmeda M; Sanmartín JL; Fernández-García A; Cruz I; Fernández de Larrea N; Molina M; Rodríguez-Cabrera F; Martín M; Merino-Amador P; León Paniagua J; Muñoz-Montalvo JF; Blanco F; Yotti R;
    Lancet; 2020 Aug; 396(10250):535-544. PubMed ID: 32645347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional differences in colorectal cancer mortality trends, Spain (1980-2018).
    Cayuela L; Rodríguez-Domínguez S; Giráldez Á; Cayuela A
    Rev Esp Enferm Dig; 2021 Aug; 113(8):570-575. PubMed ID: 33261500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Has stroke mortality stopped declining in Spain?
    Cayuela A; Cayuela L; Ortega Belmonte MJ; Rodríguez-Domínguez S; Escudero-Martínez I; González A
    Neurologia (Engl Ed); 2022 Sep; 37(7):550-556. PubMed ID: 34521606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Has stroke mortality stopped declining in Spain?
    Cayuela A; Cayuela L; Ortega Belmonte MJ; Rodríguez-Domínguez S; Escudero-Martínez I; González A
    Neurologia (Engl Ed); 2022 Sep; 37(7):550-556. PubMed ID: 31780318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized multicenter clinical trial to evaluate the efficacy of melatonin in the prophylaxis of SARS-CoV-2 infection in high-risk contacts (MeCOVID Trial): A structured summary of a study protocol for a randomised controlled trial.
    García IG; Rodriguez-Rubio M; Mariblanca AR; de Soto LM; García LD; Villatoro JM; Parada JQ; Meseguer ES; Rosales MJ; González J; Arribas JR; Carcas AJ; de la Oliva P; Borobia AM
    Trials; 2020 Jun; 21(1):466. PubMed ID: 32493475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydroxychloroquine efficacy and safety in preventing SARS-CoV-2 infection and COVID-19 disease severity during pregnancy (COVID-Preg): a structured summary of a study protocol for a randomised placebo controlled trial.
    González R; García-Otero L; Pons-Duran C; Marbán-Castro E; Goncé A; Llurba E; Gil MDM; Rodríguez-Zambrano MÁ; Chen H; Ramírez M; Bardají A; Menendez C
    Trials; 2020 Jul; 21(1):607. PubMed ID: 32616063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 infection in patients on renal replacement therapy. Report of the COVID-19 Registry of the Spanish Society of Nephrology (SEN).
    Sánchez-Álvarez JE; Pérez Fontán M; Jiménez Martín C; Blasco Pelícano M; Cabezas Reina CJ; Sevillano Prieto ÁM; Melilli E; Crespo Barrios M; Macía Heras M; Del Pino Y Pino MD
    Nefrologia (Engl Ed); 2020; 40(3):272-278. PubMed ID: 32389518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimates of the severity of coronavirus disease 2019: a model-based analysis.
    Verity R; Okell LC; Dorigatti I; Winskill P; Whittaker C; Imai N; Cuomo-Dannenburg G; Thompson H; Walker PGT; Fu H; Dighe A; Griffin JT; Baguelin M; Bhatia S; Boonyasiri A; Cori A; Cucunubá Z; FitzJohn R; Gaythorpe K; Green W; Hamlet A; Hinsley W; Laydon D; Nedjati-Gilani G; Riley S; van Elsland S; Volz E; Wang H; Wang Y; Xi X; Donnelly CA; Ghani AC; Ferguson NM
    Lancet Infect Dis; 2020 Jun; 20(6):669-677. PubMed ID: 32240634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing the Impact of the COVID-19 Pandemic in Spain: Large-Scale, Online, Self-Reported Population Survey.
    Oliver N; Barber X; Roomp K; Roomp K
    J Med Internet Res; 2020 Sep; 22(9):e21319. PubMed ID: 32870159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcutaneous Sarilumab in hospitalised patients with moderate-severe COVID-19 infection compared to the standard of care (SARCOVID): a structured summary of a study protocol for a randomised controlled trial.
    Garcia-Vicuña R; Abad-Santos F; González-Alvaro I; Ramos-Lima F; Sanz JS
    Trials; 2020 Sep; 21(1):772. PubMed ID: 32907638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of lockdown on the outcomes of COVID-19 in Spain: An ecological study.
    Siqueira CADS; Freitas YNL; Cancela MC; Carvalho M; Oliveras-Fabregas A; de Souza DLB
    PLoS One; 2020; 15(7):e0236779. PubMed ID: 32726363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-specific SARS-CoV-2 infection fatality ratio and associated risk factors, Italy, February to April 2020.
    Poletti P; Tirani M; Cereda D; Trentini F; Guzzetta G; Marziano V; Buoro S; Riboli S; Crottogini L; Piccarreta R; Piatti A; Grasselli G; Melegaro A; Gramegna M; Ajelli M; Merler S
    Euro Surveill; 2020 Aug; 25(31):. PubMed ID: 32762797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimation of SARS-CoV-2 mortality during the early stages of an epidemic: A modeling study in Hubei, China, and six regions in Europe.
    Hauser A; Counotte MJ; Margossian CC; Konstantinoudis G; Low N; Althaus CL; Riou J
    PLoS Med; 2020 Jul; 17(7):e1003189. PubMed ID: 32722715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
    Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
    Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.